Interview: NCCIH Director Josephine Briggs On The Science Supporting More Self-Care
This article was originally published in The Tan Sheet
In an interview with “The Tan Sheet,” Briggs discusses topics including the lack of data on drug-supplement interactions and NCCIH’s interest in funding research on standards for assessing the clinical importance of those interactions.
You may also be interested in...
NCCIH Director Josephine Briggs will depart the center after nine years, with deputy director David Shurtleff serving as acting director; the 10th Circuit will not rehear MusclePharm's complaint against insurer; blood sugar supplement firm receives FDA warning letter; more news in brief.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.